Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 5A2 pseudogene 1 (EIF5A2P1) is a human pseudogene that shares sequence similarity with the protein-coding gene EIF5A2 (eukaryotic translation initiation factor 5A2)[1][4]. Unlike the functional EIF5A2 gene, EIF5A2P1 does not code for a protein and lacks a known biological function, molecular activity, or involvement in disease processes. It is not considered a therapeutic target, receptor, enzyme, transporter, or otherwise actionable entity in pharmacology or biomedical research[1][4]. Pseudogenes like EIF5A2P1 often result from gene duplication or retrotransposition events and typically lack coding potential due to mutations or regulatory defects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 5A2 pseudogene 1 (EIF5A2P1).